ABBV - CIK 0001551152
The table below shows AbbVie Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.39B | $5.63B | $6.47B | $5.17B | $7.26B | $13.13B |
| Short-term investments | - | $42.00M | $0.00 | $1.00M | $28.00M | $27.00M |
| Receivables | $12.48B | $12.77B | $12.64B | $12.48B | $11.47B | $11.72B |
| Inventory | $5.05B | $4.94B | $4.96B | $4.53B | $4.45B | $4.22B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $33.53B |
| $28.54B |
| $29.26B |
| $27.68B |
| $27.79B |
| $33.82B |
| Property, plant & equipment | $5.69B | $5.48B | $5.28B | $5.24B | $5.14B | $5.02B |
| Goodwill | $35.57B | $35.63B | $35.64B | $35.28B | $35.30B | $33.39B |
| Total assets | $136.46B | $133.90B | $137.18B | $136.16B | $143.42B | $141.94B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $42.10B | $39.39B | $39.77B | $36.40B | $43.06B | $41.91B |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$17.87B | -$14.23B | -$11.50B | -$9.53B | -$4.96B | -$3.77B |
| Total equity | -$6.66B | -$2.64B | -$183.00M | $1.42B | $6.03B | $6.78B |